Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management.
Roche’s personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. Roche has over 80 000 employees worldwide and invested over 8 billion Swiss francs in R&D in 2011.
In addition to supporting a large number of humanitarian projects and promoting scientific research, it has a long-standing commitment to contemporary art as a means of expressing innovation. Thus Roche has provided funding for the Mario Botta-designed Museum Tinguely in Basel since 1996.
The Roche Group also sponsors Roche Commissions, a joint project with Lucerne Festival and the Lucerne Festival Academy, in which new orchestral works from contemporary composers are commissioned and receive their public premiere. It also promotes challenging jazz since 2007 and, in the context of “Roche Continents”, sponsors the “Salzburg contemporary” concert series at the Salzburg Festival.
Additional information about the Roche Group is available on the Internet at: